Sino Biopharmaceutical | 1177 - Current Liabilities


Sino Biopharmaceutical reported CNY24.85B in Current Liabilities for its fiscal semester ending in June of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Cspc Pharmaceutical CNY 10.18B 65.36M Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Jiangsu Hengrui CNY 6.37B 1.48B Dec/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Sino Biopharmaceutical CNY 24.85B 5.29B Jun/2025
Tectonic Therapeutic USD 9.67M 293K Dec/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 109.57M 6.63M Dec/2025